Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of July 21, 2026, CSBR trades at $6.15 with a market cap of $85.13M and a P/E ratio of 18.03. CSBR moved +0.00% today. Year to date, CSBR is -11.59%; over the trailing twelve months it is -27.03%. Its 52-week range spans $4.07 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CSBR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $6.15 |
| Market Cap | $85.13M |
| P/E Ratio | 18.03 |
| EPS | $0.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.99 |
| 52-Week Low | $4.07 |
| Volume | 352 |
| Avg Volume | 0 |
| Revenue (TTM) | $56.94M |
| Net Income | $4.70M |
| Gross Margin | 50.15% |
CSBR analyst coverage data. Average price target: $0.00.